BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30737899)

  • 1. [Trend Analysis of Clinical Epidemiological Characteristics of Lung Cancer in Yunnan Cancer Hospital from 2005 to 2014].
    Lin Y; Zhang Q; Lu Y; Huang Y; Ma J; Zhou Y
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):142-149. PubMed ID: 32102133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradigm Shift in Lung Cancer Therapy: Imaging and Clinical Implications.
    Erasmus JJ; Truong MT
    J Thorac Imaging; 2017 Sep; 32(5):275. PubMed ID: 28832413
    [No Abstract]   [Full Text] [Related]  

  • 3. Qualitative and quantitative imaging features of pulmonary subsolid nodules: differentiating invasive adenocarcinoma from minimally invasive adenocarcinoma and preinvasive lesions.
    Qi L; Lu W; Yang L; Tang W; Zhao S; Huang Y; Wu N; Wang J
    J Thorac Dis; 2019 Nov; 11(11):4835-4846. PubMed ID: 31903274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10-Year (2005-2014) Retrospective Clinical Epidemiological Study.
    Men Y; Wang L; Zhang Y; Gao S; Li J; Wu N; Yang B; Liu S; Ren J; Huang Y; Wang D; Liao X; Xing X; Du L; Yang L; Liu Y; Zhang Y; Wei D; Liu Y; Zhang K; Qiao Y; Shi J; Chen W; Dai M; Hui Z
    Front Oncol; 2019; 9():786. PubMed ID: 31482071
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk prediction models for lung cancer: Perspectives and dissemination.
    Tang W; Peng Q; Lyu Y; Feng X; Li X; Wei L; Li N; Chen H; Chen W; Dai M; Wu N; Li J; Huang Y
    Chin J Cancer Res; 2019 Apr; 31(2):316-328. PubMed ID: 31156302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity.
    Li M; Xi J; Zhang H; Jin X; Zhang J; Feng M; Zhan C; Wang Q
    Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):320-328. PubMed ID: 35644565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Ultrasound-Guided Core Biopsy Driven by FDG-avid Supraclavicular Lymph Nodes in Patients With Suspected Lung Cancer.
    Wang T; Liu J; Lv N; Xuan S; Bai L; Ji B; Gao S
    Front Med (Lausanne); 2021; 8():803500. PubMed ID: 35127759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging for the Pretreatment Staging of Small cell Lung Cancer: A Systematic Review.
    Mitchell MD; Aggarwal C; Tsou AY; Torigian DA; Treadwell JR
    Acad Radiol; 2016 Aug; 23(8):1047-56. PubMed ID: 27259379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging modalities for the staging of patients with colorectal cancer.
    Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
    Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer imaging methods in China from 2005 to 2014: A national, multicenter study.
    Hou DH; Zhao SJ; Shi JF; Wang L; Wang DB; Huang YC; Liao XZ; Xing XJ; Du LB; Yang L; Liu YQ; Zhang YZ; Wei DH; Liu YY; Zhang K; Li N; Chen WQ; Qiao YL; He J; Dai M; Wu N;
    Thorac Cancer; 2019 Apr; 10(4):708-714. PubMed ID: 30737899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging non-small cell lung cancer with whole-body PET.
    Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
    Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
    Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
    Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in staging early lung cancer: a randomized trial.
    Maziak DE; Darling GE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Miller JD; Gu CS; Cline KJ; Evans WK; Levine MN
    Ann Intern Med; 2009 Aug; 151(4):221-8, W-48. PubMed ID: 19581636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
    Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful or necessary?
    Cho H; Lee HY; Kim J; Kim HK; Choi JY; Um SW; Lee KS
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):514-20. PubMed ID: 26189165
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.